| Literature DB >> 15228159 |
P Baumann1, C Hiemke, S Ulrich, I Gaertner, M L Rao, G Eckermann, M Gerlach, H J Kuss, G Laux, B Müller-Oerlinghausen, P Riederer, G Zernig.
Abstract
TDM of psychotropic drugs is widely used, but there is little consensus regarding its optimal use in the clinical context. This prompted a multidisciplinary group comprised of clinical biochemists, clinical pharmacologists, and psychiatrists of the AGNP (Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie) to provide a consensus guideline. This will allow clinical psychiatrists, practitioners, and laboratory directors involved in psychopharmacotherapy to optimize TDM of antidepressants, antipsychotics, and opioid substituents. Recommendations are also given on the combined use of TDM and pharmacogenetic tests.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15228159 DOI： 10.1097/00007691-200404000-00014
Source DB: PubMed Journal: Ther Drug Monit ISSN： 0163-4356 Impact factor: 3.681